Clinical Trial Update: Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant pemetrexed and cisplatin before surgery in Non-Small-Cell Lung Cancer was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-06-02